絞り込み

17092

広告

「"Rutkowski P "[Author]」の検索結果

365件中 21件~40件表示    検索結果をPubMedで見る PubMedで見る

KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.

Standard Hot Pressing as a Possible Solution to Obtain Dense KNaNbO Ceramic Doped by ErO and YbO.

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

Quiz. What is your diagnosis?

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice.

The Horizontal Raphe of the Human Retina and its Watershed Zones.

Health-related quality of life in patients with fully resected BRAF mutation-positive melanoma receiving adjuvant vemurafenib.

Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.

Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction-single-center experience.

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors.

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure.

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs.

Plasma lncRNA expression profile as a prognostic tool in mutant metastatic melanoma patients treated with BRAF inhibitor.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります